ETAR Blockade’s Role in Current and Emerging Therapies for IgAN– Explore the Visual Abstract
This visual abstract was supported by an unrestricted educational grant from Chinook Therapeutics, a Novartis Company.
“I Really Liked the Idea of Giving Back to People in Other Parts of the World.” Larry Greenbaum on Being an ISN Mentor – Inspired? Apply by March 1!
ISN mentee Priya Pais (back row, third from left) and ISN mentor Larry Greenbaum (front row, third from right) during his three-day visit to St John's National Academy of Health Sciences in Bangalore as part of their collaboration through the ISN Mentorship Program Through the ISN Mentorship Program, Larry Greenbaum, from the Emory University School...
What is the ISN Doing About the Challenge of Chronic Kidney Disease of Unknown Origin?
Despite ongoing efforts, chronic kidney disease of unknown origin (CKDu) remains a significant, persistent challenge in several world regions. As part of its commitment to advancing equitable kidney care worldwide, the ISN launched the ISN i3C (CKDu) Network at WCN 2017 to facilitate global CKDu-related collaboration and data collection and dissemination. Explore the details of...
Latest ISN Journal Editorial Selections
Kidney International® Executive Summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis The Kidney Disease: Improving Global Outcomes (KDIGO) has updated its Glomerular Diseases Guideline for lupus nephritis (LN) in response to accelerated drug development and new insights from genetic and molecular studies. Read the updated guideline here The most significant change involves...
“Integral in Enabling Me to Start My Research Career”: ISN Clinical Research Program Facilitates Groundbreaking Study on Dialysis in Zimbabwe
Rumbidzai Dahwa received an ISN Clinical Research Program (CRP) grant for the research project "Prevalence of Chronic Kidney Disease in Zimbabwe" in 2017. Find out more about the CRP and how to apply here. The study, completed in 2020, was the first to provide comprehensive data on the nature and prevalence of dialysis in Zimbabwe and...
Get a Head Start on Your ISN Clinical Research Program Application – Watch Our Webinar for Tips on Applying!
Read the application guidelines and eligibility criteria or apply directly here if you are an ISN member. Watch the webinar at the ISN Academy. The application deadline is May 1, but your ISN regional coordinator must review proposals by April 1. Find out who your regional coordinator is here. The ISN Clinical Research Program supports research and education initiatives that help detect and manage noncommunicable chronic diseases...
Tackling the CKDu Puzzle: Read the ISN i3C Working Group’s Position Statement on Kidney Biopsies
Despite ongoing efforts, chronic kidney disease of unknown origin (CKDu) remains a significant, persistent problem in several world regions. The ISN i3C (CKDu) Working Group has written a comprehensive position statement offering vital guidance and recommendations for kidney biopsies in individuals suspected of CKDu. Read "Kidney Biopsies Among Persons Living in Hotspots of CKDu: A...
The ISN Applauds Ten New ISN-Named Fellows
Please join us in congratulating: Michele Provenzano for ISN-ACT (clinical trials) Anna Strasma for ISN i3C CKDu (chronic kidney disease of unknown origin) Winston Fung, Anukul Ghimire, Georgina Irish, Sabine Karam, Yannick Nlandu, Anna Petrova, Samveg Shah and Elliot Tannor for ISN-GKHA (Global Kidney Health Atlas) Get to know our ISN-Named Fellows here. These early-career ISN members were approved as...
A Year of Achievements in Research Skills Development Led by the YNC’s Capacity Building Sub-Committee, Featuring a Sneak Preview of 2024 Activities
By Andrea Viecelli As this year's chair of the ISN Young Nephrologists Committee's Capacity Building Sub-Committee, I had the opportunity to lead an amazing team of young kidney health professionals to build capacity and improve leadership skills, clinical workforce management, and research. Young nephrologists, particularly those practicing in low-income countries, have consistently acknowledged research as a...
From Complement-Mediated Kidney Diseases to Research Skills: Use ISN Toolkits to Implement Guidelines Effectively and Translate Evidence Into Practice
Ensure you're well-equipped in the global effort to combat kidney diseases by exploring, utilizing and sharing these valuable ISN resources. CKD Early Identification & Intervention Toolkit To address the burden of chronic kidney disease (CKD) and its impact on global morbidity, the ISN and KDIGO collaborated on a series of tools for CKD early identification and...
Final Modules Now Available: Complete the ISN YNC Curriculum and Gain Exclusive Access to a Webinar on Statistics for Clinical Research
Modules 5 and 6 of the CME-accredited ISN YNC Curriculum: Basics of Statistics for a Successful Start in Clinical Research are now available at the ISN Academy. Access Modules 5 and 6 now! (Join/renew your ISN membership to access this content) Module 5: Learn the applications of big data and machine learning in clinical research through...
Efficacy of Gravity-driven Continuous Flow Peritoneal Dialysis in Children
Rupesh Raina, ISN-ACT Global Trials Focus Subgroup member, summarizes the design and outcomes of one of the team's latest trial selections. Read all the latest global trial selections from the ISN-ACT initiative here. The "Trial of the month" is available in several languages. Gravity-assisted Continuous Flow Peritoneal Dialysis Technique Use in Acute Kidney Injury in Children: A...
Latest ISN Journal Editorial Selections
Precision medicine framework for optimizing CKD treatment Kidney International® Trends and Perspectives for Improving Quality of Chronic Kidney Disease Care: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference The conference discussed improving chronic kidney disease (CKD) diagnosis, care safety, and patient well-being, identifying current tools, barriers, and research needs in CKD management. Discussions acknowledged that...
Enhancing Scientific Writing Skills in Turkey: Testimonials From Course Participants
From left to right: Caner Alparslan, ISN Young Nephrologists Committee member (Turkey); SWC faculty members Rümeyza Kazancioğlu (Turkey), Hans Peter Marti (Norway), and Zdenka Hruskova (Czech Republic); and host and BANTAO president Mustafa Arici (Turkey)* The ISN held a Scientific Writing Course (SWC) in Istanbul from October 5-7 at Istanbul University's central campus. During the three-day...
Letermovir Non-inferior to Valganciclovir for CMV Prophylaxis, With Lower Leukopenia Rates
ISN-ACT Global Trials Focus Subgroup member Maria Chiara Pelle summarizes the design and outcomes of one of the ISN-ACT Global Trials Focus’ latest trial selections. Read all the latest global trial selections from the ISN-ACT initiative here. The “trial of the month” is available in several languages. Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-risk Kidney Transplant...
ISN Journal Editorial Selections
Kidney International® A Prospective Controlled, Randomized Clinical Trial of Kidney Transplant Recipients Developed Personalized Tacrolimus Dosing Using Model-based Bayesian Prediction In this study, a population pharmacokinetic (PPK) model, incorporating factors such as genetics, age, and hematocrit, was developed and validated to optimize tacrolimus (Tac) dosage for kidney transplant recipients. PPK-based dosing was compared with traditional weight-based dosing....
ISN Grants Transforming Kidney Care Globally: Meet the Latest Recipients
The ISN is delighted to announce the results of its latest grant application period. We are pleased to welcome participants from fifteen countries worldwide: Six new ISN Fellows who will receive training to help them establish or improve local care in their home regions. The awardees are from Fiji, Kenya, Nigeria, the Solomon Islands and...
Balanced Crystalloid Fluids May Reduce Delayed Graft Function in Deceased Donor Kidney Transplantation – New Selection of Global Trials Out Now
To stay updated on the latest research and developments in kidney care, access the latest selection of global trials from the ISN-ACT initiative here in multiple languages. ISN-ACT Global Trials Focus Coordinator Michele Provenzano summarizes the design and outcomes of the ISN-ACT Global Trials Focus’ latest “Trial of the Month.” Balanced Crystalloid Solution Versus Saline in...
The 2023 ISN-GKHA: Shaping the Future of Kidney Health Worldwide – Access Region-specific Data and Use the Findings in Your Research
The 2023 ISN-Global Kidney Health Atlas (ISN-GKHA) is driving positive change in kidney care on a global scale, and you can play a role in this transformation! Assessing global kidney care: ISN-GKHA's comprehensive analysis for informed health policies The ISN-GKHA is a comprehensive resource offering an overview of the current readiness, capacity, and competence for kidney...
Use of Self-educational Materials Can Help Decrease Dietary Salt Intake in CKD Patients – Trial Summary and Commentary
Anastasiia Zykova, ISN Advancing Clinical Trials Network member, summarizes the design and outcomes of a study from the ISN-ACT Global Trials Focus' most recent global trials selection. Evaluation of a simple, low-cost intervention to empower people with chronic kidney disease to reduce their dietary salt intake: OxCKD1, a multi-center randomized controlled trial. Summary In this trial, 193 adult participants...